SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063022
Filing Date
2023-11-13
Accepted
2023-11-13 16:30:40
Documents
77
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bior-20230930.htm   iXBRL 10-Q 2615692
2 EX-10.2 bior-ex10_2.htm EX-10.2 149982
3 EX-31.1 bior-ex31_1.htm EX-31.1 19094
4 EX-31.2 bior-ex31_2.htm EX-31.2 19861
5 EX-32.1 bior-ex32_1.htm EX-32.1 17131
  Complete submission text file 0000950170-23-063022.txt   10397915

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bior-20230930_pre.xml EX-101.PRE 474244
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bior-20230930.xsd EX-101.SCH 68473
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bior-20230930_lab.xml EX-101.LAB 613418
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bior-20230930_cal.xml EX-101.CAL 56157
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bior-20230930_def.xml EX-101.DEF 317098
71 EXTRACTED XBRL INSTANCE DOCUMENT bior-20230930_htm.xml XML 1572876
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39334 | Film No.: 231399325
SIC: 2834 Pharmaceutical Preparations